文献速递主动脉疾病

IgG4相关主动脉瘤患者白介素(IL-6、IL-10、IL-13)表达上调

Upregulated interleukins (IL-6, IL-10, and IL-13) in immunoglobulin G4-related aortic aneurysm patients.
PubMed 文献 · J Vasc Surg · 2017-04-20

本研究对IgG4相关主动脉瘤(IgG4-AA)患者、非IgG4相关炎性腹主动脉瘤患者、动脉粥样硬化性腹主动脉瘤(aAAA)患者及主动脉无扩张者的血清与主动脉组织进行细胞因子谱评估。结果显示IgG4-AA患者血清IL-6升高且与外膜厚度及血清IgG4水平正相关,外膜IL-6阳性细胞增多,局部IL-10、IL-13上调与Th2/Treg优势细胞因子平衡相关。

要点

  • IgG4-AA患者血清IL-6中位数78.5 pg/mL,显著高于非IgG4-AAA、aAAA及正常主动脉对照。
  • 外膜IL-6阳性细胞中位数17.8/高倍视野,显著高于aAAA及正常主动脉。
  • 局部IL-10、IL-13上调与血清IgG4水平相关,提示Th2/Treg优势平衡。

核心结论

  • IgG4-AA细胞因子谱表现为局部IL-10和IL-13上调(类似其他IgG4-RD的Th2/Treg优势平衡)及外膜IL-6上调。
  • 外膜间充质细胞和巨噬细胞参与的IL-6合成与IgG4-AA的发病或进展密切相关。

研究设计与样本

  • 研究纳入IgG4-AA患者10例、非IgG4相关炎性腹主动脉瘤患者5例、动脉粥样硬化性腹主动脉瘤患者10例及主动脉无扩张者10例。
  • 检测血清IL-10、IL-13、IL-6水平,并用免疫组化及原位杂交评估主动脉组织CD34、CD163及IL-6表达。

主要发现

  • IgG4-AA患者血清IL-10中位数1.3 pg/mL,高于非IgG4-AAA、aAAA及正常主动脉者。
  • 仅2例IgG4-AA患者血清IL-13高于标准值,其他组未检出。
  • IgG4-AA患者血清IL-6中位数78.5 pg/mL,分别高于非IgG4-AAA(P=.01)、aAAA(P=.001)及正常主动脉者(P=.004)。
  • 血清IL-6与血清IgG4水平及外膜厚度正相关,其他细胞因子无此相关性。
  • IgG4-AA外膜IL-6阳性细胞中位数17.8/高倍视野,高于aAAA(P=.001)及正常主动脉者(P=.002)。

关键数值与推荐

  • 血清IL-6升高的组间比较:IgG4-AA vs 非IgG4-AAA P=.01,vs aAAA P=.001,vs 正常主动脉 P=.004。
  • 外膜IL-6阳性细胞比较:IgG4-AA vs aAAA P=.001,vs 正常主动脉 P=.002。
  • 原位杂交证实IgG4-AA外膜内皮、间充质细胞及组织细胞常见IL-6 mRNA表达,并检测到IL-6与CD34 mRNA或CD163 mRNA共表达。

临床怎么用

  • 对IgG4相关主动脉瘤患者,血清IL-6及外膜IL-6表达可作为评估免疫活化状态与疾病进展的参考指标。
  • IL-6通路可能成为IgG4-AA发病或进展干预的潜在靶点。

局限性

  • 各组样本量较小(IgG4-AA 10例、非IgG4-AAA 5例、aAAA 10例、正常主动脉10例)。
  • 为单中心横断面血清与组织观察性研究,未报告随访结局或治疗干预数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Immunoglobulin (Ig) G4-related aortic aneurysms (IgG4-AAs) are a special aortic aneurysm among IgG4-related diseases (IgG4-RDs), which are inflammatory and fibrous conditions characterized by tumorous swelling of affected organs and high serum IgG4 concentrations. Recently, IgG4-RD pathogenesis was shown to be associated with T-helper-2 (Th2) and regulatory T (Treg) dominant cytokine production, such as interleukin (IL)-4, IL-10, and IL-13. IL-6 is a key proinflammatory cytokine contributing to lymphocyte and plasmacyte maturation and to atherosclerosis and aneurysm development. We serologically and histopathologically evaluated the cytokine profile in IgG4-AA patients. METHODS: Patients with IgG4-AAs (n = 10), non-IgG4-related inflammatory abdominal aortic aneurysms (non-IgG4-AAAs; n = 5), atherosclerotic AAAs (aAAAs; n = 10), and normal aortas without dilatation (n = 10) were examined for serum IL-10, IL-13, and IL-6 levels. Resected aortic tissues were evaluated for cluster of differentiation (CD) 34 (in the endothelial cells and mesenchymal cells) and CD163 (by macrophages) expression using immunohistochemistry and in situ hybridization. RESULTS: Serum IL-10 levels were rather higher in IgG4-AA patients (median, 1.3 pg/mL) than in non-IgG4-AAA and aAAA patients and in patients with normal aortas. Elevated serum IL-13 levels relative to standard values were detected in two IgG4-AA patients but not in the other groups. Cells immunopositive for IL-10 and IL-13 were more frequent in IgG4-AAs and significantly correlated with serum IgG4 levels. Serum IL-6 levels (median, 78.5 pg/mL) were also significantly higher in IgG4-AA patients than in non-IgG4-AAA and aAAA patients and control patients with normal aortas (P = .01, P = .001, and P = .004, respectively). They positively correlated with serum IgG4 levels and adventitial thickness, but other cytokines did not. The number of IL-6-immunopositive cells in the adventitia was significantly higher in IgG4-AA patients (median, 17.8/high-power field) than in aAAA patients or patients with normal aortas (P =.001 and P = .002, respectively). In situ hybridization confirmed frequent IL-6 messenger (m)RNA expression in the endothelium, mesenchymal cells, and histiocytes in IgG4-AA adventitia. In the same cells of IgG4-AAs, coexpression of IL-6 and CD34 mRNA or CD163 mRNA was detected. CONCLUSIONS: The cytokine profiles of IgG4-AA patients had two characteristics: local IL-10 and IL-13 upregulation in IgG4-AAs was related to Th2 and Treg-predominant cytokine balance, similar to other IgG4-RDs, and IL-6 upregulation in the adventitia was characterized by activated immune reactions in IgG4-AA patients. IL-6 synthesis, through contributions of mesenchymal cells and macrophages in the adventitia, is strongly involved in IgG4-AA pathogenesis or progression, or both.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kasashima S, Kawashima A, Zen Y, et al. Upregulated interleukins (IL-6, IL-10, and IL-13) in immunoglobulin G4-related aortic aneurysm patients. J Vasc Surg. 2017. PMID: 28434701. doi:10.1016/j.jvs.2016.12.140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。